Literature DB >> 26681071

Patient quality of life following induction of oral immunotherapy for food allergy.

Na'ama Epstein Rigbi1, Yitzhak Katz1,2,3, Michael R Goldberg3, Michael B Levy3, Liat Nachshon3, Arnon Elizur1,2,3.   

Abstract

BACKGROUND: Patient quality of life improves following successful completion of oral immunotherapy (OIT), but the process itself might have undesirable effects. We aimed to evaluate patient quality of life following OIT initial induction.
METHODS: The Hebrew version of the Food Allergy Quality of Life Questionnaire-Parental Form (FAQLQ-PF) was validated and administered to the parents of children following the first week of OIT for food allergy (n = 119). Patient demographics and clinical history as well as the course of initial induction week were reviewed.
RESULTS: Pre-OIT severity of food allergy, defined as severity of reactions due to accidental exposure to the allergenic food (anaphylactic reactions, p = 0.017; epinephrine use, p = 0.049; emergency room referrals p = 0.003; and hospital admissions, p = 0.015) and a lower number of tolerated doses during initial induction, reflective of a lower maximal tolerated dose for the different allergens (p = 0.011) were associated with worse total FAQLQ-PF scores. The number of tolerated doses during induction and pre-OIT emergency room referrals remained significantly associated with worse total score of the FAQLQ-PF on multivariate analysis (p = 0.016 and p = 0.005, respectively). The correlation between the number of tolerated doses and quality of life scores was moderate-strong primarily in children aged 6-12 years (Total score, r = -0.41, p = 0.001; Emotional Impact r = -0.42, p = 0.001; Food Anxiety, r = -0.38, p = 0.002; Social and Dietary Limitations, r = -0.33, p = 0.009).
CONCLUSIONS: Pre-OIT reaction severity affects quality of life in both preschool and school-aged food-allergic children. In contrast, a lower maximal tolerated dose during OIT induction is associated with worse indices of quality of life primarily in children aged 6-12 years.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  anaphylaxis; food allergy; induction; oral immunotherapy

Mesh:

Year:  2016        PMID: 26681071     DOI: 10.1111/pai.12528

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  4 in total

Review 1.  Update on oral immunotherapy for egg allergy.

Authors:  François Graham; Natacha Tardio; Louis Paradis; Anne Des Roches; Philippe Bégin
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

Review 2.  Quality of Life Among Food Allergic Patients and Their Caregivers.

Authors:  Christopher M Warren; Alana K Otto; Madeline M Walkner; Ruchi S Gupta
Journal:  Curr Allergy Asthma Rep       Date:  2016-05       Impact factor: 4.806

Review 3.  GRADE-ing the Benefit/Risk Equation in Food Immunotherapy.

Authors:  Bettina Duca; Nandinee Patel; Paul J Turner
Journal:  Curr Allergy Asthma Rep       Date:  2019-04-25       Impact factor: 4.806

4.  Psychological needs and support among patients and families undergoing food oral immunotherapy.

Authors:  Laura Polloni; Antonella Muraro; Roberta Bonaguro; Alice Toniolo; Anna Ballin; Alberto Guarnaccia; Francesca Lazzarotto
Journal:  Clin Transl Allergy       Date:  2022-02-03       Impact factor: 5.871

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.